Skip to main content
SpringerLink
Log in

Palifermin in Myelotoxic Therapy-Induced Oral Mucositis

A Viewpoint by Mohamad Mohty and Didier Blaise

  • Adis Drug Profile
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Unite de Transplantation et de Therapie Cellulaire, Institut Paoli-Calmettes, Marseille, France

    Mohamad Mohty & Didier Blaise

Authors
  1. Mohamad Mohty
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Didier Blaise
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mohty, M., Blaise, D. Palifermin in Myelotoxic Therapy-Induced Oral Mucositis. Drugs 65, 2147 (2005). https://doi.org/10.2165/00003495-200565150-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200565150-00009

Keywords

Search

Navigation